Screener
Zevra Therapeutics, Inc. ZVRA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s total assets?
- Zevra Therapeutics, Inc. (ZVRA) reported total assets of $302.71M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s total assets changed year-over-year?
- Zevra Therapeutics, Inc.'s total assets increased by 18.1% year-over-year, from $256.28M to $302.71M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total assets has grown at a 91.0% compound annual growth rate (CAGR), from $11.21M to $284.73M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Zevra Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude